We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Study of Fruit Fly Genes Unlocks Secrets Hidden in Massive Human Gene Analogues

By LabMedica International staff writers
Posted on 02 Jul 2012
The value of the lowly fruit fly (Drosophila melanogaster) to modern genomic research has been demonstrated once again in a study that used a simplified fly gene to explain the function of two mammalian genes that are too large to be studied by conventional techniques.

The two mammalian genes are the histone lysine methyltransferases MLL2 and MLL3. More...
Each of these genes contains more than 15,000 base pairs - more than 10 times the number found in a typical gene. These genes are of interest because recent research has found that several types of cancer included non-Hodgkin lymphoma, colorectal cancer, kidney cancer, bladder cancer, medulloblastoma, breast cancer, and prostate cancer are linked to MLL2 and MLL3 mutations.

Phylogenetic analyses revealed that the ancestor of these genes underwent a fission event in the distant past and that in the fruit fly each of these genes became two smaller genes. In a study published in the June 1, 2012, issue of the journal Development investigators at Loyola University (Chicago, IL, USA) presented results of genomic analysis of the fly genes TRR and CMI, which are the smaller analogues of MLL2 and MLL3.

“Evolution has given us a gift,” said senior author Dr. Andrew K. Dingwall, associate professor of pathology at Loyola University. “These fruit fly genes give us unique insight into the massive human MLL2 and MLL3 genes that are almost impossible to study because they are so large.”

Research will continue in order to discover the function of the fruit fly genes by inducing various mutations into them and then observing the effects on the flies. Ultimately, this type of study will lead to better understanding of the effects of mutations in the MLL2 and MLL3 genes, which trigger the uncontrolled reproduction of cancer cells in humans.

Related Links:

Loyola University




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.